GL1X · GenesisL1 explorer

MolNFT v1 · #154450 · protein

Crystal structure of plasmodium lysyl-tRNA synthetase in complex with a cladosporin derivative 3

6KBF · Lysine--tRNA ligase: “Crystal structure of plasmodium lysyl-tRNA synthetase in complex with a cladosporin derivative 3”. X-ray diffraction, 2 ligands (LYS, D4X), 15 pockets (best druggability 0.83). MolNFT v1 #154450 on GenesisL1…

PDB
6KBF
Type
protein
Length
1,007 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysine--tRNA ligase
EC
6.1.1.6
UniProt
W7JP72
Ligands
LYS, D4X
Pockets
15 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine--tRNA ligase (EC 6.1.1.6)protein50434% helix, 25% strandW7JP72
BLysine--tRNA ligase (EC 6.1.1.6)protein50334% helix, 25% strandW7JP72

Ligands and binding sites

  • LYS · Lysine · ligand · 2 copies · chains A, B
  • D4X · (3~{S})-3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6, 8-bis(oxidanyl)-3,4-dihydro-2~{H}-isoquinolin-1-one · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 5 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12350.830.9660GOL
27180.790.8473LYS, D4X
39120.780.8188LYS, D4X
42880.750.8732empty
52740.740.8735empty

Interfaces

1 interface between chains.

  • A–B · 4535 Ų buried · 61 hydrogen bonds · protein-protein

Compared structures

  • 6KBF · Crystal structure of plasmodium lysyl-tRNA synthetase in complex with a cladosporin… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.